In recent years, the healthcare industry has been evolving rapidly, influenced by a combination of technological advancements, the need for more personalized patient care, and a greater demand for convenient healthcare solutions. As part of this transformation, telehealth services and compounding pharmacies have seen significant growth and increasingly integrated their offerings to meet patients’ specific medical needs. This article delves deeper into the key developments and trends within the compounding pharmacy market, highlighting major players, recent moves, and the market’s projected growth.
The compounding pharmacy market, which involves the creation of personalized medications for individual patients, has gained considerable traction due to the rising demand for tailored therapeutic solutions. In 2023, the global compounding pharmacy market size was valued at US$ 13.19 billion. Projections indicate that the market will grow at a compound annual growth rate (CAGR) of 5.15%, reaching a size of US$ 22.91 billion by 2034. This growth is driven by several factors, most notably the increasing patient demand for high-quality, specialized medications that cannot be found in standard pharmaceutical offerings.
Get All the Details in Our Solution – Download Brochure @ https://www.towardshealthcare.com/download-brochure/5338
As the global healthcare system moves toward a more patient-centric approach, compounded medications are filling critical gaps in patient care. For example, patients with specific allergies, sensitivities to certain ingredients, or those who require medications in unique dosages or delivery methods (such as creams, liquids, or gels) benefit from the personalized services offered by compounding pharmacies. This demand is expected to grow exponentially, especially as new therapies for chronic conditions, hormone imbalances, and pain management continue to emerge.
A standout development in the telehealth space came in August 2024 when Hims & Hers, a leading telehealth company known for its focus on mental health, sexual health, and weight-loss medications, made a significant strategic decision to diversify its offerings. The company announced its acquisition of a compounding pharmacy, marking its foray into the personalized medicine sector.
This acquisition reflects a larger trend in telehealth companies recognizing the importance of offering not just consultations but also customized treatments. By acquiring a compounding pharmacy, Hims & Hers can now provide its patients with medications tailored to their specific needs, such as hormone therapies, specialized pain medications, or customized skincare treatments. This move allows Hims & Hers to strengthen its position in the healthcare space by offering an integrated approach, where patients can consult with healthcare professionals and simultaneously receive bespoke prescriptions, all through an accessible telemedicine platform.
Hims & Hers’ expansion into compounding pharmacy operations represents a growing trend of telehealth companies integrating more services, blurring the lines between digital health consultations and traditional pharmacy services. By creating a more comprehensive healthcare ecosystem, the company aims to improve patient outcomes through a holistic, personalized approach.
Another significant player in the compounding pharmacy market, Revelation Pharma, made waves in September 2024 by announcing the expansion of its nationwide compounding network. Revelation’s 503A and 503B compounding pharmacies now offer Revelation Wholesale, a nationwide service tailored to healthcare providers who require specialty drugs and compounded medications for their patients.
This expansion is an essential response to the increasing demand for specialty drugs, particularly in the treatment of complex health conditions where off-the-shelf medications may not suffice. Revelation Wholesale simplifies the ordering process for healthcare providers, making it easier for them to access high-quality compounded medications without having to navigate the complexities of dealing with multiple suppliers.
Revelation Pharma’s initiative is a reflection of the growing market trend in compounding pharmacies: to not only serve individual patients but also streamline supply chains for healthcare professionals. By providing a bulk supply service, Revelation is tapping into the needs of the broader healthcare ecosystem, ensuring that pharmacies and clinicians have easier access to the customized medications they require. This further boosts the accessibility and availability of compounded medicines.
In November 2023, Precision Compounding Pharmacy received a notable investment from Right Side Capital Management, a technology startup investment group. Precision Compounding is renowned for its integration of telemedicine with pharmacy services, allowing patients to receive compounded medications prescribed through virtual consultations.
The infusion of capital from Right Side Capital Management is expected to fuel the company’s growth and enable it to assist more patients through its telehealth and telepharmacy services. The unique model of Precision Compounding — which blends telemedicine with personalized drug dispensing — reflects the growing intersection between technology and healthcare, helping bridge the gap between remote consultations and personalized prescriptions.
This investment will enable Precision Compounding to scale its operations, expanding its reach to more patients in need of specialized compounded treatments. It is an example of how technology-driven solutions are reshaping the compounding pharmacy industry, enhancing both patient access and medication delivery efficiency.
Compounding pharmacies specialize in creating customized medications for patients based on their unique medical needs. These pharmacies can create formulations that are not commercially available, providing tailored solutions for conditions that require specialized drug delivery methods or dosages. This personalized approach allows patients to receive medication in a form that best suits their preferences or medical conditions, whether it is a specific dosage, an allergy-free ingredient, or a form such as a transdermal cream, suppository, or liquid.
In addition to their ability to cater to specific patient needs, compounding pharmacies play an essential role in treating rare or niche conditions that require medications not found in mainstream pharmaceutical offerings. Whether it’s creating a custom dosage of a life-saving drug or formulating a medication for a child with difficulty swallowing pills, compounding pharmacies offer flexibility and precision in a way that traditional pharmacies cannot.
Several key companies are leading the charge in providing these personalized services:
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/compounding-pharmacy-market-sizing
Invest in Our Premium Strategic Solution @ https://www.towardshealthcare.com/price/5338
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The global thyroid cancer diagnostics market is experiencing steady growth as advancements in medical technologies continue to enhance early detection,… Read More
The global autoimmune disease diagnostics market is poised for significant growth in the coming decade. Market forecasts indicate a surge… Read More
The Europe dermal filler market is witnessing remarkable growth, fueled by rising beauty consciousness, advancements in non-invasive aesthetic procedures, and… Read More
The AI in cancer drugs market is on a remarkable growth path, poised to generate substantial revenue between 2025 and… Read More
The global biostimulants market is on a steady rise. Valued at USD 3.06 billion in 2024, it's expected to grow… Read More
The dental insurance market is booming. In 2024, it was valued at $232.07 billion, grew to $253.72 billion in 2025,… Read More